ORKA Smart Money
Oruka Therapeutics, Inc.
1W: +21.1%
1M: +13.8%
3M: +8.8%
YTD: +238.9%
1Y: +251.6%
3Y: +631.4%
5Y: +441.9%
$95.81
+5.48 (+6.07%)
Pre-Market: $96.18 (+0.37, +0.38%)
Weekly Expected Move ±6.7%
$69
$75
$80
$86
$91
Credit Risk of going bust: lower than 89% of companies Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down more than 99.9%), Oruka Therapeutics, Inc. would be worth roughly what it owes.
Total debt $2.5M against a stock market value of $6.34B.
Distance to default 13.34 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $669K (short-term plus half of long-term), stock volatility 67.3%; Altman Z'' 50.48. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.00 (down more than 99.9%), Oruka Therapeutics, Inc. would be worth roughly what it owes.
Total debt $2.5M against a stock market value of $6.34B.
Distance to default 13.34 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $669K (short-term plus half of long-term), stock volatility 67.3%; Altman Z'' 50.48. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026285
Institutions Holding
+82 vs prior
108.9%
Ownership
+69.23%
103
New
94
Increased
73
Reduced
26
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-20 | Quinlan Paul T | officer: general counsel | S-Sale | 3,000 | $79.49 | $238K | Filing |
| 2026-10-20 | Quinlan Paul T | officer: general counsel | S-Sale | 4,100 | $78.79 | $323K | Filing |
| 2026-10-20 | Quinlan Paul T | officer: general counsel | S-Sale | 1,000 | $77.20 | $77K | Filing |
| 2026-10-20 | Quinlan Paul T | officer: general counsel | S-Sale | 500 | $76.12 | $38K | Filing |
| 2026-10-20 | Quinlan Paul T | officer: general counsel | S-Sale | 400 | $74.90 | $30K | Filing |
| 2026-10-15 | Goncalves Joana | officer: chief medical officer | S-Sale | 200 | $77.71 | $16K | Filing |
| 2026-10-15 | Goncalves Joana | officer: chief medical officer | S-Sale | 700 | $76.67 | $54K | Filing |
| 2026-10-15 | Goncalves Joana | officer: chief medical officer | S-Sale | 1,400 | $75.48 | $106K | Filing |
| 2026-10-15 | Goncalves Joana | officer: chief medical officer | S-Sale | 1,847 | $74.69 | $138K | Filing |
| 2026-10-15 | Goncalves Joana | officer: chief medical officer | S-Sale | 2,853 | $73.89 | $211K | Filing |
| 2026-10-12 | Agarwal Arjun | officer: senior vice president, finance | S-Sale | 2,100 | $80.76 | $170K | Filing |
| 2026-10-12 | Agarwal Arjun | officer: senior vice president, finance | S-Sale | 5,741 | $80.03 | $459K | Filing |
| 2026-10-12 | Agarwal Arjun | officer: senior vice president, finance | S-Sale | 1,958 | $81.86 | $160K | Filing |
| 2026-10-12 | Agarwal Arjun | officer: senior vice president, finance | S-Sale | 200 | $82.83 | $17K | Filing |
| 2026-10-01 | Klein Lawrence Otto | officer: chief executive officer | S-Sale | 200 | $84.78 | $17K | Filing |
| 2026-10-01 | Klein Lawrence Otto | officer: chief executive officer | S-Sale | 8,554 | $84.03 | $719K | Filing |
| 2026-10-01 | Klein Lawrence Otto | officer: chief executive officer | S-Sale | 16,246 | $83.40 | $1.4M | Filing |
| 2026-09-21 | Quinlan Paul T | officer: general counsel | S-Sale | 2,667 | $95.31 | $254K | Filing |
| 2026-09-21 | Quinlan Paul T | officer: general counsel | S-Sale | 601 | $94.44 | $57K | Filing |
| 2026-09-21 | Quinlan Paul T | officer: general counsel | S-Sale | 3,832 | $93.32 | $358K | Filing |
| 2026-09-21 | Quinlan Paul T | officer: general counsel | S-Sale | 2,900 | $92.37 | $268K | Filing |
| 2026-09-21 | Agarwal Arjun | officer: senior vice president, finance | S-Sale | 533 | $95.75 | $51K | Filing |
| 2026-09-15 | Agarwal Arjun | officer: senior vice president, finance | S-Sale | 560 | $95.71 | $54K | Filing |
| 2026-09-15 | Goncalves Joana | officer: chief medical officer | S-Sale | 947 | $95.71 | $91K | Filing |
| 2026-09-15 | Goncalves Joana | officer: chief medical officer | S-Sale | 2,384 | $91.10 | $217K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| FMR LLC | 9,057,645 | $862M | +1,626,242 | 2026-06-30 | Filing |
| BlackRock, Inc. | 4,990,181 | $475M | +1,463,094 | 2026-06-30 | Filing |
| Venrock Adviser, LLC | 4,148,428 | $395M | — | 2026-06-30 | Filing |
| Fairmount Funds Management LLC | 3,705,262 | $353M | — | 2026-06-30 | Filing |
| Capital World Investors | 3,401,639 | $324M | +3,401,639 | 2026-06-30 | Filing |
| RTW INVESTMENTS, LP | 3,139,030 | $299M | +1,080,882 | 2026-06-30 | Filing |
| STATE STREET CORP | 2,673,090 | $254M | +1,059,629 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,360,971 | $225M | +501,340 | 2026-06-30 | Filing |
| Paradigm Biocapital Advisors LP | 2,144,526 | $204M | -175,790 | 2026-06-30 | Filing |
| Deep Track Capital, LP | 1,926,000 | $183M | -108,203 | 2026-06-30 | Filing |
| Bellevue Group AG | 1,657,190 | $158M | +1,150,182 | 2026-06-30 | Filing |
| FRANKLIN RESOURCES INC | 1,621,451 | $154M | +617,395 | 2026-06-30 | Filing |
| Remedium Capital Partners, LLC | 1,565,661 | $149M | — | 2026-06-30 | Filing |
| RA CAPITAL MANAGEMENT, L.P. | 1,554,597 | $148M | +1,554,597 | 2026-06-30 | Filing |
| VIKING GLOBAL INVESTORS LP | 1,503,478 | $143M | -1,163,212 | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 1,429,954 | $136M | +475,087 | 2026-06-30 | Filing |
| Jupiter Topco LLC | 1,375,844 | $131M | +1,375,844 | 2026-06-30 | Filing |
| PERCEPTIVE ADVISORS LLC | 1,345,063 | $128M | -50,438 | 2026-06-30 | Filing |
| Polar Capital Holdings Plc | 1,228,609 | $117M | +180,916 | 2026-06-30 | Filing |
| CITADEL ADVISORS LLC | 1,119,011 | $106M | +111,474 | 2026-06-30 | Filing |